Essentiale Forte N (Phospholipids) 300 mg

Essentiale Forte N (Phospholipids) 300 mg

To favorites
Essentiale Forte N hepatoprotective agent, prevention of recurrent gallstone formation, psoriasis
Active substance:phospholipids
Pharmacological group:Hepatoprotectors
Dosage mg:300
In stock
In stock
In stock
We deliver goods to almost any country. Each parcel is assigned a track number
You can pay by Paypal or any card Visa or Mastercard
Discount system
Cumulative discounts and Bonus program for our clients
Original goods
We offer our customers only original products

Instructions for Essentiale Forte N (Phospholipids) 300 mg

English product name
Essentiale® forte N

Release form

Description Essentiale Forte N:

The capsules are solid gelatine, opaque, №1, brown in colour and contain an oily paste-like mass in a yellowish-brown colour.

1 cap.
phospholipids from soybeans containing 76% (3-sn-phosphatidyl)choline (synonyms - EPL, essential phospholipids) 300 mg
Auxiliary substances: Fat is solid - 57,000 mg, soybean oil - 36,000 mg, castor oil hydrated - 1.600 mg, ethanol 96% - 8.100 mg, ethylvanillin - 1.500 mg, 4-methoxiacetophenone - 0.800 mg, α-tocopherol - 0.750 mg.

Capsule composition:
gelatin - 67.945 mg, water purified - 11.495 mg, titanium dioxide (E171) - 0.830 mg, iron oxide yellow (E172) - 2.075 mg, iron oxide black (E172) - 0.332 mg, iron oxide red (E172) - 0.198 mg, sodium lauryl sulfate - 0.125 mg.

10 pcs - PVC and aluminium foil blisters, PVC/PTFE and aluminium foil blisters or PVC/PE/PVC and aluminium foil packs (3, 9, 18) - cardboard packs.
10 pcs - PVC and aluminium foil blisters, PVC/PTFE and aluminium foil blisters or PVC/PE/PVC and aluminium foil packs (9) - cardboard packs (2) - cardboard boxes.

ATC codes
A05C Combination of preparations for the treatment of liver and biliary diseases

Clinical-pharmacological groups / Group affiliation

Active substance
essential phospholipids

Pharmacotherapy group
Hepatoprotective agent

Storage Conditions
The drug should be stored in a place inaccessible to children at a temperature not higher than 21 ° C.

Best before date
Shelf life - for capsules packed in PVC blister and aluminum foil - three years; for capsules packed in PVC/PTFE blister and aluminium foil or PVC/PE/PVC and aluminium foil - 30 months.
Do not use the drug after the expiry date indicated on the package.

Testimony Essentiale Forte N:

  • chronic hepatitis;
  • cirrhosis;
  • fatty liver dystrophy of various etiology;
  • toxic liver damage;
  • alcoholic hepatitis;
  • Liver dysfunction in other somatic diseases;
  • pregnancy toxicosis;
  • prevention of recurrence of gallstone formation;
  • psoriasis (as an aid therapy);
  • radiation syndrome.

Method of use, course and dosage Essentiale Forte N:

The drug is taken inside. The capsules should be swallowed whole, washed with enough water (about 1 glass).
For teenagers over 12 years of age and with a body weight of more than 43 kg, as well as for adults, Essentiale® Fort H is recommended to take two capsules 3 times/day during meals.
The recommended course of therapy is three months. The course can be individually determined by a doctor

  • Nosology Essentiale Forte N (ICD codes)
  • B18.0
  • Chronic viral hepatitis B with delta agent
  • B18.1
  • Chronic viral hepatitis B without delta agent
  • B18.2
  • Chronic viral hepatitis C
  • K70
  • Alcoholic liver disease
  • K71
  • Toxic liver failure
  • K73
  • Chronic hepatitis not classified elsewhere
  • K74
  • Fibrosis and cirrhosis
  • K76.0
  • Fatty liver (liver degeneration) not classified elsewhere
  • K77.8
  • Liver damage from other diseases classified in other headings
  • K80
  • Gallstone disease [cholelitiasis] (incl. hepatic colic)
  • L40
  • Psoriasis
  • O21
  • Excessive vomiting of pregnant women
  • T66
  • Unspecified radiation effects (radiation sickness)

pharmachologic effect Essentiale Forte N:

Essential phospholipids are the basic elements of cell envelope structure and cellular organelles. Liver disease always causes damage to liver cell casings and their organelles, which leads to impaired activity of related enzymes and receptor systems, impaired functional activity of liver cells and reduced regeneration capacity.

Active substance
Pharmacological group
Dosage mg
Country of origin
Expiration Date (in months)
No reviews yet — your comment may be first.
All reviews 0
general rating